Overview

Early Childhood Malaria Prevention With Maloprim in The Gambia

Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
A trial was conducted in the 1980s to compare two strategies for control of malaria in young children aged 3-59 months: treatment with chloroquine versus treatment combined with fortnightly chemoprophylaxis with Maloprim. The impact on mortality and morbidity was assessed at the time, and their cognitive abilities and educational outcomes were assess 14 years later in 2001. The hypothesis was that the chemoprophylaxis would reduce morbidity and mortality and would improve cognitive abilities and educational outcomes in the long term
Phase:
Phase 4
Details
Lead Sponsor:
Imperial College London
Collaborators:
Government of the Gambia
London School of Hygiene and Tropical Medicine
Medical Research Council Unit, The Gambia
Partnership for Child Development
Wellcome Trust
Treatments:
Maloprim